ZA200902607B - Method for preparing Medetomidine and its salts - Google Patents
Method for preparing Medetomidine and its saltsInfo
- Publication number
- ZA200902607B ZA200902607B ZA200902607A ZA200902607A ZA200902607B ZA 200902607 B ZA200902607 B ZA 200902607B ZA 200902607 A ZA200902607 A ZA 200902607A ZA 200902607 A ZA200902607 A ZA 200902607A ZA 200902607 B ZA200902607 B ZA 200902607B
- Authority
- ZA
- South Africa
- Prior art keywords
- salts
- preparing medetomidine
- medetomidine
- preparing
- transmetalation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- HRLIOXLXPOHXTA-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CN=C[N]1 HRLIOXLXPOHXTA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002140 medetomidine Drugs 0.000 title abstract 2
- UIFVCPMLQXKEEU-UHFFFAOYSA-N 2,3-dimethylbenzaldehyde Chemical compound CC1=CC=CC(C=O)=C1C UIFVCPMLQXKEEU-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000004795 grignard reagents Chemical class 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 238000006478 transmetalation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06123548A EP1918282A1 (en) | 2006-11-06 | 2006-11-06 | Method for preparing medetomidine and its salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200902607B true ZA200902607B (en) | 2010-04-28 |
Family
ID=37770375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200902607A ZA200902607B (en) | 2006-11-06 | 2009-04-16 | Method for preparing Medetomidine and its salts |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7902377B2 (xx) |
| EP (2) | EP1918282A1 (xx) |
| JP (1) | JP2010508332A (xx) |
| KR (1) | KR20090052398A (xx) |
| CN (1) | CN101535272B (xx) |
| AT (1) | ATE517094T1 (xx) |
| AU (1) | AU2007316693B2 (xx) |
| BR (1) | BRPI0714992A2 (xx) |
| CA (1) | CA2660365C (xx) |
| DK (1) | DK2079706T3 (xx) |
| EA (1) | EA200900355A1 (xx) |
| ES (1) | ES2369746T3 (xx) |
| MX (1) | MX2009004649A (xx) |
| NZ (1) | NZ575125A (xx) |
| PL (1) | PL2079706T3 (xx) |
| PT (1) | PT2079706E (xx) |
| SI (1) | SI2079706T1 (xx) |
| WO (1) | WO2008055852A1 (xx) |
| ZA (1) | ZA200902607B (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011070069A1 (en) | 2009-12-09 | 2011-06-16 | I-Tech Ab | Process for preparation of medetomidine |
| CN102452984B (zh) * | 2010-10-21 | 2013-10-23 | 桑迪亚医药技术（上海）有限责任公司 | 4-[1-(2,3-二甲基苯基)乙烯基]-1-r1-2-r2咪唑的合成方法 |
| EP2734508B1 (en) | 2011-07-22 | 2018-02-28 | Cambrex Karlskoga Ab | New processes for preparing 4-substituted imidazoles |
| IN2014DN07982A (xx) | 2012-05-08 | 2015-05-01 | Lonza Ag | |
| WO2012172119A2 (en) | 2012-05-08 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine |
| EA025950B1 (ru) | 2012-05-08 | 2017-02-28 | Лонца Лтд. | Способ получения медетомидина |
| IN2014DN07984A (xx) * | 2012-06-28 | 2015-05-01 | Lonza Ag | |
| WO2012172121A1 (en) * | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine with chloroacetone |
| US9126914B1 (en) * | 2012-06-28 | 2015-09-08 | Lonza Ltd. | Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone |
| WO2012172122A2 (en) | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal |
| CN103588711B (zh) | 2013-11-27 | 2015-04-08 | 天津炜捷制药有限公司 | 一种美托咪定中间体的制备方法 |
| CN103664788B (zh) * | 2013-12-04 | 2015-11-25 | 湖北生物医药产业技术研究院有限公司 | 制备美托咪啶的方法 |
| CN104447562A (zh) * | 2014-03-27 | 2015-03-25 | 宁波天衡药业股份有限公司 | 一种制备盐酸右美托咪定关键中间体的新方法 |
| CN106083724B (zh) * | 2016-08-02 | 2018-06-26 | 江苏恒瑞医药股份有限公司 | 一种右美托咪定的制备方法 |
| CN111269192A (zh) * | 2020-02-25 | 2020-06-12 | 成都睿智化学研究有限公司 | 一种5-羟甲基四氮唑及其衍生物的合成方法 |
| CN114671811A (zh) * | 2022-04-14 | 2022-06-28 | 南京正科医药股份有限公司 | 一种右美托咪定拆分副产物的外消旋化回收方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2069481B (en) * | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| KR20070054213A (ko) * | 2004-09-24 | 2007-05-28 | 알러간, 인코포레이티드 | 특이적인 알파2 아드레날린성 아고니스트로서 작용하는4-(페닐메틸 및 치환된 페닐메틸)-이미다졸-2-티온 |
| MX2007003094A (es) * | 2004-09-24 | 2007-06-07 | Allergan Inc | 4-(metilo ciclico condensado)-imidazol-2-tionas como agonistas alfa2 adrenergicos. |
-
2006
- 2006-11-06 EP EP06123548A patent/EP1918282A1/en not_active Withdrawn
-
2007
- 2007-11-02 BR BRPI0714992-1A patent/BRPI0714992A2/pt not_active IP Right Cessation
- 2007-11-02 AT AT07822154T patent/ATE517094T1/de active
- 2007-11-02 CA CA2660365A patent/CA2660365C/en active Active
- 2007-11-02 EA EA200900355A patent/EA200900355A1/ru unknown
- 2007-11-02 ES ES07822154T patent/ES2369746T3/es active Active
- 2007-11-02 DK DK07822154.6T patent/DK2079706T3/da active
- 2007-11-02 CN CN2007800358734A patent/CN101535272B/zh not_active Expired - Fee Related
- 2007-11-02 PL PL07822154T patent/PL2079706T3/pl unknown
- 2007-11-02 US US12/312,324 patent/US7902377B2/en active Active
- 2007-11-02 KR KR1020097007913A patent/KR20090052398A/ko not_active Ceased
- 2007-11-02 EP EP07822154A patent/EP2079706B1/en active Active
- 2007-11-02 SI SI200730737T patent/SI2079706T1/sl unknown
- 2007-11-02 WO PCT/EP2007/061822 patent/WO2008055852A1/en not_active Ceased
- 2007-11-02 AU AU2007316693A patent/AU2007316693B2/en not_active Ceased
- 2007-11-02 PT PT07822154T patent/PT2079706E/pt unknown
- 2007-11-02 NZ NZ575125A patent/NZ575125A/en not_active IP Right Cessation
- 2007-11-02 MX MX2009004649A patent/MX2009004649A/es not_active Application Discontinuation
- 2007-11-02 JP JP2009535083A patent/JP2010508332A/ja active Pending
-
2009
- 2009-04-16 ZA ZA200902607A patent/ZA200902607B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008055852A1 (en) | 2008-05-15 |
| WO2008055852A8 (en) | 2009-05-22 |
| PL2079706T3 (pl) | 2011-12-30 |
| SI2079706T1 (sl) | 2011-11-30 |
| EP2079706A1 (en) | 2009-07-22 |
| US20100048915A1 (en) | 2010-02-25 |
| EP1918282A1 (en) | 2008-05-07 |
| CN101535272A (zh) | 2009-09-16 |
| NZ575125A (en) | 2011-02-25 |
| PT2079706E (pt) | 2011-10-19 |
| AU2007316693A1 (en) | 2008-05-15 |
| ATE517094T1 (de) | 2011-08-15 |
| CA2660365A1 (en) | 2008-05-15 |
| US7902377B2 (en) | 2011-03-08 |
| EA200900355A1 (ru) | 2009-10-30 |
| EP2079706B1 (en) | 2011-07-20 |
| CA2660365C (en) | 2014-03-25 |
| KR20090052398A (ko) | 2009-05-25 |
| JP2010508332A (ja) | 2010-03-18 |
| AU2007316693B2 (en) | 2012-02-02 |
| CN101535272B (zh) | 2011-10-05 |
| DK2079706T3 (da) | 2011-10-03 |
| ES2369746T3 (es) | 2011-12-05 |
| MX2009004649A (es) | 2009-05-21 |
| BRPI0714992A2 (pt) | 2013-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200902607B (en) | Method for preparing Medetomidine and its salts | |
| UA107443C2 (uk) | Хімічний спосіб | |
| GB2427317B (en) | Quantum key distribution apparatus & method | |
| IL214183A (en) | Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation | |
| EP1854219A4 (en) | METHOD, APPARATUS AND SYSTEM FOR TRANSMITTING ENERGY | |
| GB0512229D0 (en) | Quantum key distribution apparatus & method | |
| PL2124381T3 (pl) | Sposób, system i urządzenie do generowania klucza grupowego | |
| PL1875463T3 (pl) | Układy, sposoby i urządzenie do wygładzania współczynnika wzmocnienia | |
| SG166091A1 (en) | Method for producing isocyanates | |
| EP2347996A4 (en) | PROCESS FOR PRODUCING CARBONITRIDE MIXTURE PARTICLE OR OXYCARBONITRIDE MIXTURE PARTICLE, AND USE THEREOF | |
| TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
| IL178000A0 (en) | Method and system for advancing funds | |
| SG145591A1 (en) | System and method for electroplating metal components | |
| EP1955399A4 (en) | METHOD AND DEVICE FOR PRODUCING HYDROGEN | |
| EP1878714A4 (en) | ORGANIC HYDRIDE SYNTHESIS DEVICE, ORGANIC HYDRIDE SYNTHESIS SYSTEM, AND HYDROGEN PRODUCTION DEVICE | |
| TW200619205A (en) | A method for preparing irbesartan and intermediates thereof | |
| WO2007053284A3 (en) | Method of treating breast cancer using 17-aag or 17-ag or a prodrug of either in combination with a her2 inhibitor | |
| GB0812662D0 (en) | Data processing apparatus, for example using modes | |
| EP1931563A4 (en) | RESISTANCE, DRIVE AND DRIVE GENERATION SYSTEM | |
| WO2010148177A3 (en) | Compounds, compositions, methods of synthesis, and methods of treatment | |
| GB2432233B (en) | User-interface system, method & apparatus | |
| IL179335A0 (en) | Reactor for generating moisture and moisture generating and feeding apparatus using the same | |
| MX2008001638A (es) | Metodo de espaciado de piel entumecida. | |
| EP1892642A4 (en) | SERVICE TRANSFER SYSTEM, SERVICE WITH EQUIPMENT, TEMPLATE TRANSMITTER | |
| GR1005773B (el) | Διαταξη δια τη συλλογη καρπων |